Interesting, maybe can lead to new forms of treatment?
Arul M. Chinnaiyan, University of Michigan, USA, is awarded this year’s Sjöberg Prize, worth one million US dollars, for his discovery of the fusion gene responsible for more than half of all prostate cancer cases. This has significantly improved our understanding of one of the most common types of cancer and already contributed to better diagnostics. It also holds great potential for improving the care of thousands of patients in the future.
Yes, it is the discovery of TMPRSS2:ERG gene fusion he is rewarded for. Do you think the discovery is worth a price? So there is a commercial test available. Do you know where/when the test is used and what the clinical value of the test result is? Thanks!
It was touted for a while as a non-PSA blood test for detection (given along with PSA-based blood tests). At the time I looked at it, it was too expensive and not covered by insurance:
Other than improving the initial detection of prostate cancer, and being one (of many) genomic risk factors for progression, I don't know of any therapeutic value.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.